These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 31192857)
1. Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment. Abbruzzese A; Venerito V; Lopalco G; Fornaro M; Giannotta M; Iannone F J Clin Rheumatol; 2020 Sep; 26(6):e208-e209. PubMed ID: 31192857 [No Abstract] [Full Text] [Related]
2. Secukinumab retreatment associated psoriasis flare with pustules. El-Komy M; Amer M; Mostafa A; ElKalioby M J Dermatolog Treat; 2022 Mar; 33(2):1107-1110. PubMed ID: 32538223 [TBL] [Abstract][Full Text] [Related]
3. A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab. Megna M; Marano L; Camela E; Potestio L; Fabbrocini G; Scalvenzi M; Guerrasio G Dermatol Ther; 2022 Oct; 35(10):e15766. PubMed ID: 35959513 [No Abstract] [Full Text] [Related]
5. Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report. Lu J; Tang S; Yu N; Yi X; Li Y J Int Med Res; 2020 Nov; 48(11):300060520969494. PubMed ID: 33161790 [TBL] [Abstract][Full Text] [Related]
6. Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis. Reich K; Baraliakos X; Coates LC; Elewski B; Bao W; Kasparek T; Gaillez C; Pournara E; Aassi M; Perella C; Gottlieb AB Br J Dermatol; 2022 Sep; 187(3):438-441. PubMed ID: 35257363 [TBL] [Abstract][Full Text] [Related]
7. Clinical improvement in psoriatic nail disease and psoriatic arthritis with tildrakizumab treatment. Ismail FF; May J; Moi J; Sinclair R Dermatol Ther; 2020 Mar; 33(2):e13216. PubMed ID: 31899569 [No Abstract] [Full Text] [Related]
8. A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab. Bernardini N; Skroza N; Marraffa F; Prevete E; Mambrin A; Proietti I; Tolino E; Caviglia M; Di Guardo A; Rossi G; Volpe S; Bersani G; Potenza C Dermatol Ther; 2022 Jul; 35(7):e15533. PubMed ID: 35460156 [No Abstract] [Full Text] [Related]
9. Comment on: 'Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab'. Akturk S; Altunisik N; Buyukavci R; Turkmen D Clin Exp Dermatol; 2022 Jul; 47(7):1363-1364. PubMed ID: 35266569 [No Abstract] [Full Text] [Related]
10. Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature. Hsieh CY; Tsai TF Lupus; 2022 Jun; 31(7):891-894. PubMed ID: 35438595 [TBL] [Abstract][Full Text] [Related]
11. Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis. Henderson Berg MH; Carrasco D J Drugs Dermatol; 2017 Jul; 16(7):695-698. PubMed ID: 28697222 [TBL] [Abstract][Full Text] [Related]
12. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis. Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677 [No Abstract] [Full Text] [Related]
13. Efficacy of secukinumab in psoriasis and psoriatic arthritis: A retrospective multicentre study. Ruiz-Villaverde R; Rodriguez-Fernandez-Freire L; Galán-Gutierrez M; Martinez-Pilar L Med Clin (Barc); 2020 May; 154(9):370-371. PubMed ID: 30717997 [No Abstract] [Full Text] [Related]
14. Adalimumab therapy of psoriasis and psoriatic arthritis in a patient with cirrhosis of the liver. Piel S; Dissemond J J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S117-8. PubMed ID: 19119119 [No Abstract] [Full Text] [Related]
15. No reactivation of tuberculosis in patients with latent tuberculosis infection receiving ixekizumab: A report from 16 clinical studies of patients with psoriasis or psoriatic arthritis. Mrowietz U; Riedl E; Winkler S; Xu W; Patel H; Agada N; Lebwohl MG J Am Acad Dermatol; 2020 Nov; 83(5):1436-1439. PubMed ID: 32526319 [No Abstract] [Full Text] [Related]
16. Use of secukinumab in a pediatric patient leads to significant improvement in nail psoriasis and psoriatic arthritis. Wells LE; Evans T; Hilton R; Wine Lee L; Ruth N Pediatr Dermatol; 2019 May; 36(3):384-385. PubMed ID: 30811618 [TBL] [Abstract][Full Text] [Related]
17. Atopic Dermatitis-like Eruption Induced by Two Different Biologics in a Patient with Psoriatic Arthritis. Abe F; Mitsuyama S; Nagao E; Kimura M; Higuchi T Acta Derm Venereol; 2019 Dec; 99(13):1291-1292. PubMed ID: 31573661 [No Abstract] [Full Text] [Related]
18. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis. Kitamura G; Mehr N; Anderson N; Sirichotiratana M Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028 [TBL] [Abstract][Full Text] [Related]
19. Secukinumab: A Review in Psoriatic Arthritis. Shirley M; Scott LJ Drugs; 2016 Jul; 76(11):1135-45. PubMed ID: 27299434 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Patients with Generalized Pustular Psoriasis and Psoriatic Arthritis: A Retrospective Cohort Study. Manome-Zenke Y; Ohara Y; Fukui S; Kobayashi D; Sugiura K; Ikeda S; Arai S Acta Derm Venereol; 2022 Apr; 102():adv00685. PubMed ID: 35312017 [No Abstract] [Full Text] [Related] [Next] [New Search]